BioNexus Gene Lab Corp (BGLC): Shareholders' Equity
$8.61M
As of 2025-12-31
$7.78M
As of 2026-06-30
+8.9%
3-year compound annual growth
+5.3%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.61M | +3.5% | 2026-04-14, Balance as of period end |
| 2024-12-31 | $8.32M | -13.8% | 2026-04-14, Balance as of period end |
| 2023-12-31 | $9.66M | +44.9% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $6.67M | -7.2% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $7.18M | +7.8% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $6.66M | +493.6% | 2022-04-06, Balance as of period end |
| 2019-12-31 | $1.12M | -26.3% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $1.52M | n/a | 2020-03-31, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $8.61M | +3.5% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.69M | -7.8% |
| Exagen Inc. (XGN) | 2025-12-31 | $17.45M | +82.9% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $261.19M | +28.7% |
| Biodesix Inc (BDSX) | 2025-12-31 | -$2.46M | n/m |
| YD Bio Ltd (YDES) | 2025-12-31 | -$2.86M | n/m |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.58B | +3.0% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $480.11M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.11B | -1.9% |
Compare BGLC, AMS, XGN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗